Page last updated: 2024-12-07
allylbenzene 2',3'-epoxide
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
allylbenzene 2',3'-epoxide: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
| ID Source | ID |
|---|---|
| PubMed CID | 94826 |
| SCHEMBL ID | 51254 |
| MeSH ID | M0242366 |
Synonyms (54)
| Synonym |
|---|
| nsc-4327 |
| oxirane, (phenylmethyl)- |
| benzene,3-epoxypropyl)- |
| 4436-24-2 |
| nsc4327 |
| benzyloxirane |
| ai3-24431 |
| 2-benzyloxirane |
| allylbenzene 2',3'-oxide |
| brn 0108023 |
| benzene, (2,3-epoxypropyl)- |
| (phenylmethyl)oxirane |
| phenylpropylene oxide |
| nsc 4327 |
| ccris 1134 |
| (2,3-epoxypropyl)benzene |
| benzylethylene oxide |
| 2',3'-epoxyallylbenzene [french] |
| allylbenzene 2',3'-epoxide |
| (2,3-epoxypropyl)benzene, 98% |
| 2-benzyl-oxirane |
| 2',3'-epoxyallylbenzene |
| allylbenzene-2',3'-oxide |
| lkq2758w1e , |
| unii-lkq2758w1e |
| AKOS009158010 |
| SCHEMBL51254 |
| 2,3-epoxypropyl benzene |
| (+/-)-(2,3-epoxypropyl)benzene |
| 1-benzyl ethylene oxide |
| 2-(phenylmethyl)oxirane |
| 3-phenylpropyleneoxide |
| (2,3-epoxypropyl)-benzene |
| 2,3-epoxypropyl-benzene |
| JFDMLXYWGLECEY-UHFFFAOYSA-N |
| s-(-)-2,3-epoxypropyl benzene |
| (2.3-epoxypropyl)benzene |
| 2,3-epoxy-propylbenzene |
| 2,3-epoxypropylbenzene |
| 1-phenyl-2,3-epoxypropane |
| oxirane, 2-(phenylmethyl)- |
| 3-phenylpropene-1,2-oxide |
| (2,3-epoxypropyl)benzene, (+/-)- |
| 2,3-epoxy-1-phenylpropane |
| 1,2-epoxy-3-phenyl-propane |
| CS-0106157 |
| F20875 |
| diethylpentanedioate |
| EN300-119884 |
| mfcd00074964 |
| Q27283046 |
| AS-75733 |
| DTXSID501032201 |
| Z1020680006 |
Research Excerpts
Toxicity
| Excerpt | Reference | Relevance |
|---|---|---|
| " We also deduce, from evidence obtained using the isolated perfused rat liver, that formation of potentially genotoxic 2',3' epoxide metabolites occurs readily in vivo, but that these metabolites are rapidly further metabolized to less toxic dihydrodiol or glutathione conjugates." | ( Investigation of the role of the 2',3'-epoxidation pathway in the bioactivation and genotoxicity of dietary allylbenzene analogs. Guenthner, TM; Luo, G, 2001) | 0.31 |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (7)
| Timeframe | Studies, This Drug (%) | All Drugs % |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (14.29) | 18.2507 |
| 2000's | 5 (71.43) | 29.6817 |
| 2010's | 1 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||
Market Indicators
Research Demand Index: 12.85
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.85) All Compounds (24.57) |
Study Types
| Publication Type | This drug (%) | All Drugs (%) |
|---|---|---|
| Trials | 0 (0.00%) | 5.53% |
| Reviews | 0 (0.00%) | 6.00% |
| Case Studies | 0 (0.00%) | 4.05% |
| Observational | 0 (0.00%) | 0.25% |
| Other | 8 (100.00%) | 84.16% |
| [information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] | ||